295 related articles for article (PubMed ID: 24486833)
1. Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma.
Joseph MM; Aravind SR; George SK; Pillai KR; Mini S; Sreelekha TT
Colloids Surf B Biointerfaces; 2014 Apr; 116():219-27. PubMed ID: 24486833
[TBL] [Abstract][Full Text] [Related]
2. PST-Gold nanoparticle as an effective anticancer agent with immunomodulatory properties.
Joseph MM; Aravind SR; Varghese S; Mini S; Sreelekha TT
Colloids Surf B Biointerfaces; 2013 Apr; 104():32-9. PubMed ID: 23298585
[TBL] [Abstract][Full Text] [Related]
3. Co-encapsulation of Doxorubicin with galactoxyloglucan nanoparticles for intracellular tumor-targeted delivery in murine ascites and solid tumors.
Joseph MM; Aravind SR; George SK; Pillai RK; Mini S; Sreelekha TT
Transl Oncol; 2014 Oct; 7(5):525-36. PubMed ID: 25389448
[TBL] [Abstract][Full Text] [Related]
4. A galactomannan polysaccharide from Punica granatum imparts in vitro and in vivo anticancer activity.
Joseph MM; Aravind SR; George SK; Varghese S; Sreelekha TT
Carbohydr Polym; 2013 Nov; 98(2):1466-75. PubMed ID: 24053828
[TBL] [Abstract][Full Text] [Related]
5. Galactoxyloglucan-modified nanocarriers of doxorubicin for improved tumor-targeted drug delivery with minimal toxicity.
Joseph MM; Aravind SR; George SK; Pillai KR; Mini S; Sreelekha TT
J Biomed Nanotechnol; 2014 Nov; 10(11):3253-68. PubMed ID: 26000385
[TBL] [Abstract][Full Text] [Related]
6. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
7. Carboxylic group-induced synthesis and characterization of selenium nanoparticles and its anti-tumor potential on Dalton's lymphoma cells.
Kumar S; Tomar MS; Acharya A
Colloids Surf B Biointerfaces; 2015 Feb; 126():546-52. PubMed ID: 25616972
[TBL] [Abstract][Full Text] [Related]
8. Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model.
Dhamija I; Kumar N; Manjula SN; Parihar V; Setty MM; Pai KS
Exp Toxicol Pathol; 2013 Mar; 65(3):235-42. PubMed ID: 21920724
[TBL] [Abstract][Full Text] [Related]
9. Influence of gold nanoparticle tagged snake venom protein toxin NKCT1 on Ehrlich ascites carcinoma (EAC) and EAC induced solid tumor bearing male albino mice.
Bhowmik T; Saha PP; DasGupta AK; Gomes A
Curr Drug Deliv; 2014; 11(5):652-64. PubMed ID: 24827982
[TBL] [Abstract][Full Text] [Related]
10. Preliminary evaluation of
Santhi R; Annapurani S
J Cancer Res Ther; 2020; 16(1):78-87. PubMed ID: 32362613
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive efficacy of Aegle marmelos on murine transplantable tumors.
George SK; Radhakrishnan R; Kumar SS; Sreelekha TT; Balaram P
Integr Cancer Ther; 2014 Jan; 13(1):68-78. PubMed ID: 23729467
[TBL] [Abstract][Full Text] [Related]
12. Antitumour activity of Annona muricata L. leaf methanol extracts against Ehrlich Ascites Carcinoma and Dalton's Lymphoma Ascites mediated tumours in Swiss albino mice.
Naik AV; Dessai SN; Sellappan K
Libyan J Med; 2021 Dec; 16(1):1846862. PubMed ID: 33380281
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: Mechanistic insights and interactome analysis.
Joseph MM; Aravind SR; George SK; Raveendran Pillai K; Mini S; Sreelekha TT
Eur J Pharm Biopharm; 2015 Jun; 93():183-95. PubMed ID: 25864443
[TBL] [Abstract][Full Text] [Related]
14. Self-assembled drug loaded glycosyl-protein metal nanoconstruct: Detailed synthetic procedure and therapeutic effect in solid tumor treatment.
Unnikrishnan BS; Maya S; Preethi GU; Anusree KS; Reshma PL; Archana MG; Kaustabh MK; Sreelekha TT
Colloids Surf B Biointerfaces; 2020 Sep; 193():111082. PubMed ID: 32361551
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of silver nanoparticles in Dalton's lymphoma ascites tumor model.
Sriram MI; Kanth SB; Kalishwaralal K; Gurunathan S
Int J Nanomedicine; 2010 Oct; 5():753-62. PubMed ID: 21042421
[TBL] [Abstract][Full Text] [Related]
16. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
Ajith TA; Anu V; Riji T
J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
[TBL] [Abstract][Full Text] [Related]
17. Effect of Au-dextran NPs as anti-tumor agent against EAC and solid tumor in mice by biochemical evaluations and histopathological investigations.
Medhat D; Hussein J; El-Naggar ME; Attia MF; Anwar M; Latif YA; Booles HF; Morsy S; Farrag AR; Khalil WKB; El-Khayat Z
Biomed Pharmacother; 2017 Jul; 91():1006-1016. PubMed ID: 28525943
[TBL] [Abstract][Full Text] [Related]
18. Sanazole directed targeting of silver nanoparticle drug complex to tumor mass: a preclinical investigation in murine model.
Nair GG; Nair CK
J Cancer Res Ther; 2014; 10(4):979-84. PubMed ID: 25579540
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of a molecularly imprinted nanopreparation of 5-flurouracil against Ehrlich's carcinoma solid tumors grown in mice: Comparison to free 5-flurouracil.
Gardouh AR; Barakat BM; Qushawy MKE; El-Kazzaz AY; Sami MM; Zaitone SA
Chem Biol Interact; 2018 Nov; 295():52-63. PubMed ID: 29678497
[TBL] [Abstract][Full Text] [Related]
20. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
